US 8252787
Protein kinase inhibitors
granted A61PA61P1/16A61P19/08
Quick answer
US patent 8252787 (Protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 51
- CPC classes
- A61P, A61P1/16, A61P19/08, A61P25/00, A61P25/28